COVID Trial Diversity: What Participants In The Vaccine Phase III Studies Look Like

 
• By Sue Sutter
Diverse population
Vaccine sponsors have adopted different approaches to disclosing diversity data for their Phase III trials. • Source: Shutterstock

More from Clinical Trials

More from R&D